<DOC>
	<DOCNO>NCT01560689</DOCNO>
	<brief_summary>The purpose study determine whether inhale Budesonide/formoterol effective treatment bronchiolitis obliterans allogeneic stem cell transplantation .</brief_summary>
	<brief_title>Inhaled BUDESONIDE/FORMOTEROL Bronchiolitis Obliterans Following Stem Cell Transplantation</brief_title>
	<detailed_description>Bronchiolitis obliterans ( BO ) life-threatening pulmonary late-onset complication follow allogenic stem cell transplantation ( SCT ) , commonly attribute graft versus host disease ( GVHD ) , carry poor prognosis . Although immunosuppressive treatment ( IS ) represent main therapeutic approach disorder , medication rarely efficient alternative approach strongly need . Because , combination inhale steroid long-acting bronchodilator know decrease respiratory symptom , prevent exacerbation improve lung function chronic obstructive pulmonary disease bronchiolar component , may beneficial effect BO . Thus , investigator conduct pilot open-labeled trial evaluate therapeutic effect inhale Budesonide/Formoterol combination ( 400/12 Âµg twice day ) without modify systemic IS receive patient .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>adult allogeneic stem cell transplant recipients clinical respiratory sign assume secondary BO , without extrathoracic extensive graft versus host disease Extensive extra thoracic GVH necessitate increase immunosuppressive treatment</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>bone marrow transplantation</keyword>
	<keyword>obstructive lung disease</keyword>
	<keyword>bronchodilator</keyword>
	<keyword>inhaled steroid</keyword>
	<keyword>late-onset pulmonary complication</keyword>
</DOC>